Lisa Dalton

Ms. Dalton has served on the board of directors since June 2, 2021. Most recently, Ms. Dalton served as Chief People Officer at Spark Therapeutics, Inc. (Roche Holdings AG). Prior to joining Spark, Ms. Dalton spent 10 years at Shire plc (now Takeda) in various leadership roles within the human resources function. Ms. Dalton also has held roles in human resources with Franklin Templeton Investments, Applied Biosystems and Goldman Sachs. Ms. Dalton serves as a member of the Board of Advisors of Life Science Cares Philadelphia and is on the External Advisory Board of the Drexel University Solution’s Institute. She also serves as an advisor on the Philadelphia Chamber of Commerce’s Cell & Gene Therapy and Connected Health Initiative committee. In 2020, Ms. Dalton was named a “Woman of Distinction” by the Philadelphia Business Journal. She holds an M.B.A from Rutgers University School of Business and a B.A. in psychology from Pennsylvania State University. We believe that Ms. Dalton is qualified to serve as a director due to her extensive experience in human resources, particularly her service as a chief people officer, her experience in the pharmaceutical industry and her educational background.